Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome

European Journal of Clinical Pharmacology

Volumn 62, Issue 1, 2006, Pages 3-8

  El Husseini, Amr ^a   El Basuony, Fathy ^a   Mahmoud, Ihab ^a   Donia, Ahmed ^a   Sheashaa, Hussein ^a   Sabry, Alaa ^a   Hassan, Nabil ^a   Sayed Ahmad, Nagy ^a   Sobh, Mohamed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Children; Cyclosporine; Ketoconazole; Nephrotic syndrome; Steroid dependent; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CAPTOPRIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KETOCONAZOLE; PREDNISOLONE; STEROID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; COST CONTROL; DEVELOPING COUNTRY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERPLASIA; GLOMERULOSCLEROSIS; HIRSUTISM; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAPTOPRIL; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; MALE; NEPHROTIC SYNDROME; RETROSPECTIVE STUDIES; STEROIDS;

EID: 30844459959     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-005-0064-0     Document Type: Article

References (33)

1. Begga A, Hari P, Moudgil A, Jordan S (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis 42:1114-1120
2. Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE (1996) Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. J Am Soc Nephrol 7:543-549
3. Neuhaus TJ, Burger HR, Klingler M, Fanconi A, Leumann EP (1992) Long-term cyclosporine therapy for pediatric nephrotic syndrome of childhood. Eur J Pediatr 151:775-778
4. Tejani A, Butt K, Trachtman H, Suthathiran M, Rothenthal CJ, Khawar MR (1988) Cyclosporine A induced remission of relapsing nephrotic syndrome of children. Kidney Int 33:729-734
5. Barclay PG, Allen RDM, Stewart JH, Ng K, Chapman JR (1992) Costs of immunosuppressive therapies used in renal transplantation. Transplant Proc 24:165-166
6. Smith SL, Hampton EM, Pederson JA (1994) Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients. Pharmacotherapy 14:471-476
7. Keogh A, Spratt P, McCosker C, Macdonald P, Mundy J, Kaan A (1995) Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 333:628-633
8. Sobh M, El-Agroudy A, Mostafa F, Harras F, El-Bedewy M, Ghoneim M (1995) Co-administration of ketoconazole to cyclosporine treated kidney transplant recipients: a prospective randomized study. Am J Nephrol 15:493-499
9. First MR, Schroeder TJ, Michela A, Hariharan S, Weiskittel P, Alexander JW (1993) Cyclosporine-ketoconazole interaction. Long-term follow up and preliminary results of a randomized trial. Transplantation 55:1000-1004
10. Jones TE (1997) The use of other drugs to allow a lower dosage of cyclosporine to be used: therapeutic and pharmacoeconomic considerations. Clin Pharmacokinet 32:357-367
11. Sobh MA, Hamdy AF, El Agroudy AE, El Sayed K, El-Diasty T, Bakr MA, Ghoneim MA (2001) Co-administration of ketoconazole and cyclosporine for kidney transplant recipients: long-term follow-up and study of metabolic consequences. Am J Kidney Dis 37:510-517
12. Meyrier A, Niaudet P, Brodehl J (1992) Optimal use of Sandimmune in nephrotic syndrome. Springer, Berlin Heidelberg New York
13. International Study of Kidney Disease in Children (1982) Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J Pediatr 101:514-518
14. International Study of Kidney Disease in Children (1982) Primary nephrotic syndrome in children. Clinical significance of histopathologic variants of minimal change and diffuse mesangial hypercellularity. Kidney Int 20:717-765
15. Tune BM, Kirpeker R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy for prednisone-resistant pediatric focal glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84-88
16. Everitt BS (1994) Statistical methods for medical investigators. 2nd edn. John Wiley & Sons, New York
17. Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K (1998) Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine. Am J Kidney Dis 31:932-939
18. Tohjoh S, Narita M, Koyama T (1994) Clinical evaluation of cyclosporine in the treatment of nephrotic syndrome: Multicenter double blind study (in Japanese). Jin To Tohseki 37:565-608
19. Berkovitch M, Bitzan M, Matsui D, Finkelstein H, Balfe JW, Koren G (1994) Pediatric clinical use of the ketoconazole/cyclosporine interaction. Pediatr Nephrol 8:492-493
20. Kramer MR, Marshall SE, Denning DW et al (1990) Cyclosporine and itraconazole in heart and lung transplant recipients. Ann Intern Med 113:327-329
21. Dieperink H, Kemp E, Leyssac PP et al (1986) Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine A concentration. Clin Nephrol 25[Suppl 1]:S137-S143
22. Buttman SM, Wild JC, Nolan PE, Fagan TC, Filney PR, Hick MJ, Capeland TG (1991) Prospective study of safety and financial benefit of ketoconazole as adjuvant therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 10:351-358
23. Glynn AM, Slaughter RL, Brass C, D'Ambrosio R, Jusko WJ (1986) Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. Clin Pharmacol Ther 39:654-659
24. Ganesan V, Milford V, Taylor C, Hulton S, Parvaresh S, Ramani P (2002) Cyclosporine-related nephrotoxicity in children with nephrotic syndrome. Pediatr Nephrol 17:225-226
25. Singh A, Tejani C, Tejani A (1999) One-center experience with cyclosporine in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26-32
26. Senior DS, Show JT (1988) In vitro effect of fluconazole and ketoconazole on mouth lymphocyte proliferation and on Canadian blastospore destruction by human polymorphonuclear leucocytes. Int J Immuno Pharmacol 10:169-176
27. Inoue Y, Iijima K, Nakamura H, Yoshikawa N (1999) Two-year cyclosporine treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol 13:33-38
28. Ingulli E, Singh A, Baqi N, Ahmad H, Moazami S, Tejani A (1995) Aggressive, long-term cyclosporine therapy for steroid resistant focal segmental glomerulosclerosis. J Am Soc Nephrol 5:1820-1825
29. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL (1999) A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North American Nephrotic Syndrome Study Group. Kidney Int 56:2220-2226
30. Chishti AS, Sorof JM, Brewer ED, Kale AS (2001) Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 38:754-760
31. Lorber MI, Van Buren CT, Flechner SM (1987) Hepatobiliary and pancreatic complications of Cyclosporine therapy in 1466 transplant recipients. Transplantation 43:35-40
32. First MR, Schroeder TJ, Alexander JW, Stephens GW, Weiskittle P, Pesce AJ (1991) Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients. Transplantation 51:365-370
33. McEvoy GK (ed) (1991) Ketoconazole. In: AHFS drug information. American Society of Health-System Pharmacists, Bethesda, pp 82-86